Clinical Trial

The Effectiveness Of BETY In Fibromyalgia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 24, 2025 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Fibromyalgia Syndrome (FMS) is a nonarticular, chronic rheumatic disorder of unknown etiology characterized by widespread musculoskeletal pain, impaired sleep quality, fatigue and the presence of identified tender points. Pain, the main symptom of the disease, is described as chronic and widespread. It is reported that the pain usually starts in the neck and shoulders but becomes widespread by being felt in various parts of the body during the day. Although it is difficult to localize the pain, it is reported to be localized to the paracervical and trapezius muscle and paralumbar and gluteal body parts. Cognitive Exercise Therapy Approach is an innovative exercise approach developed on the basis of biopsychosocial model on individuals with rheumatism. This method has a unique scale that offers biopsychosocial assessment. There is the Cognitive Exercise Therapy Approach-Biopsychosocial Questionnaire (BETY-BQ). Validity, reliability and sensitivity studies of BETY-BQ have been conducted in individuals with fibromyalgia. This study aims to examine the effect of BETY, an exercise approach developed on the basis of the biopsychosocial model, on individuals with fibromyalgia.
Trial Details
NCT Number NCT07034417
Lead Sponsor Aysima Barlak
Collaborators: Alanya Alaaddin Keykubat University, Alanya Allaaddin Keykubat University Hospital
Conditions Fibromyalgia
Enrollment 40 participants
Start Date 2025-07-12
Primary Completion 2025-08-30 (estimated)
Study Completion 2027-02-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-24